| Nov 7 |
Kenvue Non-GAAP EPS of $0.28 beats by $0.01, revenue of $3.9B misses by $20M
|
| Nov 7 |
Kenvue Reports Third Quarter 2024 Results
|
| Nov 6 |
Kenvue Q3 2024 Earnings Preview
|
| Nov 5 |
Kenvue Canada Expands Ontario Manufacturing Facility to Boost Production of Over-the-Counter Medicines
|
| Oct 31 |
Neutrogena® Launches Breakthrough Collaboration with Two of World’s Most Recognizable Dermatologists
|
| Oct 29 |
Kenvue: Unpacking Activist's Case And Earnings Preview
|
| Oct 25 |
The Score: McDonald’s, Tesla, Spirit Airlines and More Stocks That Defined the Week
|
| Oct 22 |
Starboard Hammers Pfizer Execs For Failing To Deliver On 'Best Pipeline' Promises
|
| Oct 22 |
Kenvue needs to fix its skin, health & beauty segments, Starboard's Jeff Smith says
|
| Oct 22 |
Kenvue's Double Catalysts: Starboard Stake and Dividend Announcement
|
